T Uz1, H Manev. 1. Psychiatric Institute, University of Illinois at Chicago, USA.
Abstract
BACKGROUND: It has been proposed that up-regulation of cyclic adenosine monophosphate response element binding protein is a common action of chronic antidepressant treatments that may regulate specific target genes in the hippocampus. We hypothesized that the serotonin N-acetyltransferase (AA-NAT; EC 2.3.1.87) gene is one such target. AA-NAT leads to formation of N-acetylserotonin from serotonin, and in the pineal gland, to melatonin synthesis. We investigated whether hippocampal AA-NAT expression can be modified by chronic administration of fluoxetine to rats. METHODS: Male Brown-Norway rats were administered 5 mg/kg fluoxetine or its vehicle either once (acute) or once daily for 21 days (chronic). They were sacrificed 18 hours after the last injection, and their hippocampi were processed for a quantitative reverse-transcription/polymerase-chain reaction assay of AA-NAT and cyclophilin (cyc) messenger (m)RNAs. The results are expressed as AA-NAT/cyc ratios. RESULTS: Chronic but not acute fluoxetine administration resulted in about a fivefold increase in hippocampal AA-NAT mRNA. CONCLUSIONS: Up-regulation of extrapineal, e.g., hippocampal, AA-NAT expression may play a role in mediating the therapeutic action of antidepressant drugs.
BACKGROUND: It has been proposed that up-regulation of cyclic adenosine monophosphate response element binding protein is a common action of chronic antidepressant treatments that may regulate specific target genes in the hippocampus. We hypothesized that the serotonin N-acetyltransferase (AA-NAT; EC 2.3.1.87) gene is one such target. AA-NAT leads to formation of N-acetylserotonin from serotonin, and in the pineal gland, to melatonin synthesis. We investigated whether hippocampal AA-NAT expression can be modified by chronic administration of fluoxetine to rats. METHODS: Male Brown-Norway rats were administered 5 mg/kg fluoxetine or its vehicle either once (acute) or once daily for 21 days (chronic). They were sacrificed 18 hours after the last injection, and their hippocampi were processed for a quantitative reverse-transcription/polymerase-chain reaction assay of AA-NAT and cyclophilin (cyc) messenger (m)RNAs. The results are expressed as AA-NAT/cyc ratios. RESULTS: Chronic but not acute fluoxetine administration resulted in about a fivefold increase in hippocampal AA-NAT mRNA. CONCLUSIONS: Up-regulation of extrapineal, e.g., hippocampal, AA-NAT expression may play a role in mediating the therapeutic action of antidepressant drugs.
Authors: Pradoldej Sompol; Xia Liu; Kenkichi Baba; Ketema N Paul; Gianluca Tosini; P Michael Iuvone; Keqiang Ye Journal: Proc Natl Acad Sci U S A Date: 2011-05-09 Impact factor: 11.205
Authors: Sung-Wuk Jang; Xia Liu; Sompol Pradoldej; Gianluca Tosini; Qiang Chang; P Michael Iuvone; Keqiang Ye Journal: Proc Natl Acad Sci U S A Date: 2010-02-04 Impact factor: 12.779
Authors: Hongjie Zhu; Mikhail B Bogdanov; Stephen H Boyle; Wayne Matson; Swati Sharma; Samantha Matson; Erik Churchill; Oliver Fiehn; John A Rush; Ranga R Krishnan; Eve Pickering; Marielle Delnomdedieu; Rima Kaddurah-Daouk Journal: PLoS One Date: 2013-07-17 Impact factor: 3.240